Selected research
Industry Research
Bioconjugation Service Industry Research Report 2026
Market perspective
The global Bioconjugation Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bioconjugation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bioconjugation Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bioconjugation Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bioconjugation Service include AxisPharm, CellMosaic, Bio-Synthesis, GBI, Lonza, NJ Bio, WuXi Biologics, Creative Biolabs and Biosynth, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bioconjugation Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bioconjugation Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bioconjugation Service Market by Company
AxisPharm
CellMosaic
Bio-Synthesis
GBI
Lonza
NJ Bio
WuXi Biologics
Creative Biolabs
Biosynth
Antibody Solutions
CheMatech
Thermo Fisher Scientific Inc
BOC Sciences
GTP Bioways
LifeSynth Solutions
iQ Biosciences
Macrocyclics
piramal pharma solutions
Bioconjugation Service Segment by Type
Protein Bioconjugation
Antibody Bioconjugation
Peptide Bioconjugation
Others
Bioconjugation Service Segment by Application
Pharmaceutical
Diagnostics
Biotechnology Research
Bioconjugation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioconjugation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bioconjugation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Protein Bioconjugation
- Antibody Bioconjugation
- Peptide Bioconjugation
- Others
Applications
- Pharmaceutical
- Diagnostics
- Biotechnology Research
Companies covered
- AxisPharm
- CellMosaic
- Bio-Synthesis
- GBI
- Lonza
- NJ Bio
- WuXi Biologics
- Creative Biolabs
- Biosynth
- Antibody Solutions
- CheMatech
- Thermo Fisher Scientific Inc
- BOC Sciences
- GTP Bioways
- LifeSynth Solutions
- iQ Biosciences
- Macrocyclics
- piramal pharma solutions
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bioconjugation Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Protein Bioconjugation
- 2.2.3 Antibody Bioconjugation
- 2.2.4 Peptide Bioconjugation
- 2.2.5 Others
- 2.3 Bioconjugation Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical
- 2.3.3 Diagnostics
- 2.3.4 Biotechnology Research
- 2.4 Assumptions and Limitations
3 Bioconjugation Service Breakdown Data by Type
- 3.1 Global Bioconjugation Service Historic Market Size by Type (2021-2026)
- 3.2 Global Bioconjugation Service Forecasted Market Size by Type (2027-2032)
4 Bioconjugation Service Breakdown Data by Application
- 4.1 Global Bioconjugation Service Historic Market Size by Application (2021-2026)
- 4.2 Global Bioconjugation Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bioconjugation Service Market Perspective (2021-2032)
- 5.2 Global Bioconjugation Service Growth Trends by Region
- 5.2.1 Global Bioconjugation Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bioconjugation Service Historic Market Size by Region (2021-2026)
- 5.2.3 Bioconjugation Service Forecasted Market Size by Region (2027-2032)
- 5.3 Bioconjugation Service Market Dynamics
- 5.3.1 Bioconjugation Service Industry Trends
- 5.3.2 Bioconjugation Service Market Drivers
- 5.3.3 Bioconjugation Service Market Challenges
- 5.3.4 Bioconjugation Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bioconjugation Service Players by Revenue
- 6.1.1 Global Top Bioconjugation Service Players by Revenue (2021-2026)
- 6.1.2 Global Bioconjugation Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Bioconjugation Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bioconjugation Service Head Office and Area Served
- 6.4 Global Bioconjugation Service Players, Product Type & Application
- 6.5 Global Bioconjugation Service Manufacturers Established Date
- 6.6 Global Bioconjugation Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bioconjugation Service Market Size (2021-2032)
- 7.2 North America Bioconjugation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bioconjugation Service Market Size by Country (2021-2026)
- 7.4 North America Bioconjugation Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bioconjugation Service Market Size (2021-2032)
- 8.2 Europe Bioconjugation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bioconjugation Service Market Size by Country (2021-2026)
- 8.4 Europe Bioconjugation Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bioconjugation Service Market Size (2021-2032)
- 9.2 Asia-Pacific Bioconjugation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bioconjugation Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bioconjugation Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bioconjugation Service Market Size (2021-2032)
- 10.2 South America Bioconjugation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bioconjugation Service Market Size by Country (2021-2026)
- 10.4 South America Bioconjugation Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bioconjugation Service Market Size (2021-2032)
- 11.2 Middle East & Africa Bioconjugation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bioconjugation Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bioconjugation Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AxisPharm
- 12.1.1 AxisPharm Company Information
- 12.1.2 AxisPharm Business Overview
- 12.1.3 AxisPharm Revenue in Bioconjugation Service Business (2021-2026)
- 12.1.4 AxisPharm Bioconjugation Service Product Portfolio
- 12.1.5 AxisPharm Recent Developments
- 12.2 CellMosaic
- 12.2.1 CellMosaic Company Information
- 12.2.2 CellMosaic Business Overview
- 12.2.3 CellMosaic Revenue in Bioconjugation Service Business (2021-2026)
- 12.2.4 CellMosaic Bioconjugation Service Product Portfolio
- 12.2.5 CellMosaic Recent Developments
- 12.3 Bio-Synthesis
- 12.3.1 Bio-Synthesis Company Information
- 12.3.2 Bio-Synthesis Business Overview
- 12.3.3 Bio-Synthesis Revenue in Bioconjugation Service Business (2021-2026)
- 12.3.4 Bio-Synthesis Bioconjugation Service Product Portfolio
- 12.3.5 Bio-Synthesis Recent Developments
- 12.4 GBI
- 12.4.1 GBI Company Information
- 12.4.2 GBI Business Overview
- 12.4.3 GBI Revenue in Bioconjugation Service Business (2021-2026)
- 12.4.4 GBI Bioconjugation Service Product Portfolio
- 12.4.5 GBI Recent Developments
- 12.5 Lonza
- 12.5.1 Lonza Company Information
- 12.5.2 Lonza Business Overview
- 12.5.3 Lonza Revenue in Bioconjugation Service Business (2021-2026)
- 12.5.4 Lonza Bioconjugation Service Product Portfolio
- 12.5.5 Lonza Recent Developments
- 12.6 NJ Bio
- 12.6.1 NJ Bio Company Information
- 12.6.2 NJ Bio Business Overview
- 12.6.3 NJ Bio Revenue in Bioconjugation Service Business (2021-2026)
- 12.6.4 NJ Bio Bioconjugation Service Product Portfolio
- 12.6.5 NJ Bio Recent Developments
- 12.7 WuXi Biologics
- 12.7.1 WuXi Biologics Company Information
- 12.7.2 WuXi Biologics Business Overview
- 12.7.3 WuXi Biologics Revenue in Bioconjugation Service Business (2021-2026)
- 12.7.4 WuXi Biologics Bioconjugation Service Product Portfolio
- 12.7.5 WuXi Biologics Recent Developments
- 12.8 Creative Biolabs
- 12.8.1 Creative Biolabs Company Information
- 12.8.2 Creative Biolabs Business Overview
- 12.8.3 Creative Biolabs Revenue in Bioconjugation Service Business (2021-2026)
- 12.8.4 Creative Biolabs Bioconjugation Service Product Portfolio
- 12.8.5 Creative Biolabs Recent Developments
- 12.9 Biosynth
- 12.9.1 Biosynth Company Information
- 12.9.2 Biosynth Business Overview
- 12.9.3 Biosynth Revenue in Bioconjugation Service Business (2021-2026)
- 12.9.4 Biosynth Bioconjugation Service Product Portfolio
- 12.9.5 Biosynth Recent Developments
- 12.10 Antibody Solutions
- 12.10.1 Antibody Solutions Company Information
- 12.10.2 Antibody Solutions Business Overview
- 12.10.3 Antibody Solutions Revenue in Bioconjugation Service Business (2021-2026)
- 12.10.4 Antibody Solutions Bioconjugation Service Product Portfolio
- 12.10.5 Antibody Solutions Recent Developments
- 12.11 CheMatech
- 12.11.1 CheMatech Company Information
- 12.11.2 CheMatech Business Overview
- 12.11.3 CheMatech Revenue in Bioconjugation Service Business (2021-2026)
- 12.11.4 CheMatech Bioconjugation Service Product Portfolio
- 12.11.5 CheMatech Recent Developments
- 12.12 Thermo Fisher Scientific Inc
- 12.12.1 Thermo Fisher Scientific Inc Company Information
- 12.12.2 Thermo Fisher Scientific Inc Business Overview
- 12.12.3 Thermo Fisher Scientific Inc Revenue in Bioconjugation Service Business (2021-2026)
- 12.12.4 Thermo Fisher Scientific Inc Bioconjugation Service Product Portfolio
- 12.12.5 Thermo Fisher Scientific Inc Recent Developments
- 12.13 BOC Sciences
- 12.13.1 BOC Sciences Company Information
- 12.13.2 BOC Sciences Business Overview
- 12.13.3 BOC Sciences Revenue in Bioconjugation Service Business (2021-2026)
- 12.13.4 BOC Sciences Bioconjugation Service Product Portfolio
- 12.13.5 BOC Sciences Recent Developments
- 12.14 GTP Bioways
- 12.14.1 GTP Bioways Company Information
- 12.14.2 GTP Bioways Business Overview
- 12.14.3 GTP Bioways Revenue in Bioconjugation Service Business (2021-2026)
- 12.14.4 GTP Bioways Bioconjugation Service Product Portfolio
- 12.14.5 GTP Bioways Recent Developments
- 12.15 LifeSynth Solutions
- 12.15.1 LifeSynth Solutions Company Information
- 12.15.2 LifeSynth Solutions Business Overview
- 12.15.3 LifeSynth Solutions Revenue in Bioconjugation Service Business (2021-2026)
- 12.15.4 LifeSynth Solutions Bioconjugation Service Product Portfolio
- 12.15.5 LifeSynth Solutions Recent Developments
- 12.16 iQ Biosciences
- 12.16.1 iQ Biosciences Company Information
- 12.16.2 iQ Biosciences Business Overview
- 12.16.3 iQ Biosciences Revenue in Bioconjugation Service Business (2021-2026)
- 12.16.4 iQ Biosciences Bioconjugation Service Product Portfolio
- 12.16.5 iQ Biosciences Recent Developments
- 12.17 Macrocyclics
- 12.17.1 Macrocyclics Company Information
- 12.17.2 Macrocyclics Business Overview
- 12.17.3 Macrocyclics Revenue in Bioconjugation Service Business (2021-2026)
- 12.17.4 Macrocyclics Bioconjugation Service Product Portfolio
- 12.17.5 Macrocyclics Recent Developments
- 12.18 piramal pharma solutions
- 12.18.1 piramal pharma solutions Company Information
- 12.18.2 piramal pharma solutions Business Overview
- 12.18.3 piramal pharma solutions Revenue in Bioconjugation Service Business (2021-2026)
- 12.18.4 piramal pharma solutions Bioconjugation Service Product Portfolio
- 12.18.5 piramal pharma solutions Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst